Ceftriaxone Injection, Powder, For Solution
NDC Package 66288-6100-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ceftriaxone (ceftriaxone sodium) injection is ceftriaxone is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Samson Medical Technologies, Llc, this product is identified by NDC 66288-6100 and is authorized under FDA application ANDA090057.

Identification & Billing

NDC Package Code
66288-6100-1
Package Description
1 INJECTION, POWDER, FOR SOLUTION in 1 BAG
Product Code
66288-6100
11-Digit Billing Format
66288610001
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 309090 - cefTRIAXone 100 MG/ML Injectable Solution
  • RxCUI: 309090 - ceftriaxone 100 MG/ML Injectable Solution
  • RxCUI: 309090 - ceftriaxone (as ceftriaxone sodium) 10 GM per 100 ML Injectable Solution
  • RxCUI: 309090 - ceftriaxone (as ceftriaxone sodium) 100 GM per 1000 ML Injectable Solution

Clinical Specifications

Proprietary Name
Ceftriaxone
Non-Proprietary Name
Ceftriaxone Sodium
Substance Name
Ceftriaxone Sodium
Dosage Form
Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
CEFTRIAXONE SODIUM 100 g/1
Pharmacologic Class
Usage Information
Ceftriaxone is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details.

Regulatory & Marketing

Labeler Name
Samson Medical Technologies, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA090057
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-30-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66288-6100-1 identifies a specific commercial package of 1 injection, powder, for solution in 1 bag of Ceftriaxone, a human prescription drug labeled by Samson Medical Technologies, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, for solution is formulated for intravenous use and contains ceftriaxone sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Samson Medical Technologies, Llc on June 30, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Ceftriaxone is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details.

How is this Samson Medical Technologies, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66288610001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
66288-6100-1
11-Digit CMS (5-4-2)
66288-6100-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.